Premium
Review of invasive cervical cancers and uptake of disclosure of results: an audit of procedures and response
Author(s) -
Prabakar I.,
Moss E. L.,
Douce G.,
Parkes J.,
Redman C. W. E.
Publication year - 2012
Publication title -
cytopathology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.512
H-Index - 48
eISSN - 1365-2303
pISSN - 0956-5507
DOI - 10.1111/j.1365-2303.2012.00974.x
Subject(s) - medicine , cervical cancer , audit , cervical screening , gynecology , cancer , family medicine , cervical cancer screening , obstetrics , general surgery , management , economics
I. Prabakar, E. L. Moss, G. Douce, J. Parkes and C. W. E. Redman Review of invasive cervical cancers and uptake of disclosure of results: an audit of procedures and response Objective: To audit the process and outcome of case reviews performed for invasive cervical cancers diagnosed between 2003 and 2007, and the timely disclosure of results to the respective patients. Methods: Invasive cervical cancer reviews were performed on all cases of cervical cancer diagnosed between 2003 and 2007. Following the review, women were classified into two categories: a group who developed invasive cancer despite adherence to the screening programme or in whom a management or diagnostic decision was determined to have been a principal factor in the development of their disease (Group A), and a second group who either had never undergone a cervical smear or had been established defaulters from the screening programme (Group B). Results: Ninety‐seven of the 98 cases of invasive cervical cancer diagnosed in the 4‐year study period were reviewed. Sixty of the 61 women in Group A were sent an invitation to discuss the results of their case review. Thirty‐six (37%) were classified as Group B, and it was deemed neither appropriate nor possible to invite the patients for a review consultation. Of the women sent an invitation, only 24 (40%) chose to attend. Conclusion: A policy of selective invitation for the disclosure of invasive review results is feasible. Less than one‐half of patients diagnosed with cervical cancer appear to want to know how they developed cervical cancer despite previously participating in a screening programme.